| Year |
Citation |
Score |
| 2024 |
Dukic S, Fasano A, Coffey A, Buxó T, McMackin R, Chipika R, Heverin M, Bede P, Muthuraman M, Lowery M, Carson RG, Hardiman O, Nasseroleslami B. Electroencephalographic β-band oscillations in the sensorimotor network reflect motor symptom severity in amyotrophic lateral sclerosis. European Journal of Neurology. e16201. PMID 38235854 DOI: 10.1111/ene.16201 |
0.829 |
|
| 2023 |
Metzger M, Dukic S, McMackin R, Giglia E, Mitchell M, Bista S, Costello E, Peelo C, Tadjine Y, Sirenko V, Plaitano S, Coffey A, McManus L, Farnell Sharp A, Mehra P, ... ... Hardiman O, et al. Functional network dynamics revealed by EEG microstates reflect cognitive decline in amyotrophic lateral sclerosis. Human Brain Mapping. PMID 38087950 DOI: 10.1002/hbm.26536 |
0.816 |
|
| 2023 |
Bista S, Coffey A, Fasano A, Buxo T, Mitchell M, Giglia ER, Dukic S, Heverin M, Muthuraman M, Carson RG, Lowery M, Hardiman O, McManus L, Nasseroleslami B. Cortico-muscular coherence in primary lateral sclerosis reveals abnormal cortical engagement during motor function beyond primary motor areas. Cerebral Cortex (New York, N.Y. : 1991). PMID 37143180 DOI: 10.1093/cercor/bhad152 |
0.807 |
|
| 2023 |
Adey BN, Cooper-Knock J, Al Khleifat A, Fogh I, van Damme P, Corcia P, Couratier P, Hardiman O, McLaughlin R, Gotkine M, Drory V, Silani V, Ticozzi N, Veldink JH, van den Berg LH, et al. Large-scale analyses of CAV1 and CAV2 suggest their expression is higher in post-mortem ALS brain tissue and affects survival. Frontiers in Cellular Neuroscience. 17: 1112405. PMID 36937187 DOI: 10.3389/fncel.2023.1112405 |
0.311 |
|
| 2023 |
Tahedl M, Tan EL, Shing SLH, Chipika RH, Siah WF, Hengeveld JC, Doherty MA, McLaughlin RL, Hardiman O, Finegan E, Bede P. Not a benign motor neuron disease: longitudinal imaging captures relentless motor connectome disintegration in Primary Lateral Sclerosis. European Journal of Neurology. PMID 36739888 DOI: 10.1111/ene.15725 |
0.326 |
|
| 2022 |
Chipika RH, Mulkerrin G, Murad A, Lope J, Hardiman O, Bede P. Alterations in somatosensory, visual and auditory pathways in amyotrophic lateral sclerosis: an under-recognised facet of ALS. Journal of Integrative Neuroscience. 21: 88. PMID 35633169 DOI: 10.31083/j.jin2103088 |
0.303 |
|
| 2022 |
Tahedl M, Li Hi Shing S, Finegan E, Chipika RH, Lope J, Hardiman O, Bede P. Propagation patterns in motor neuron diseases: Individual and phenotype-associated disease-burden trajectories across the UMN-LMN spectrum of MNDs. Neurobiology of Aging. 109: 78-87. PMID 34656922 DOI: 10.1016/j.neurobiolaging.2021.04.031 |
0.367 |
|
| 2021 |
Tahedl M, Li Hi Shing S, Finegan E, Chipika RH, Lope J, Murad A, Hardiman O, Bede P. Imaging data reveal divergent longitudinal trajectories in PLS, ALS and poliomyelitis survivors: Group-level and single-subject traits. Data in Brief. 39: 107484. PMID 34901337 DOI: 10.1016/j.dib.2021.107484 |
0.345 |
|
| 2021 |
Dukic S, McMackin R, Costello E, Metzger M, Buxo T, Fasano A, Chipika R, Pinto-Grau M, Schuster C, Hammond M, Heverin M, Coffey A, Broderick M, Iyer PM, Mohr K, ... ... Hardiman O, et al. Resting-state EEG reveals four subphenotypes of amyotrophic lateral sclerosis. Brain : a Journal of Neurology. PMID 34791079 DOI: 10.1093/brain/awab322 |
0.824 |
|
| 2021 |
Mahoney CJ, Ahmed RM, Huynh W, Tu S, Rohrer JD, Bedlack RS, Hardiman O, Kiernan MC. Pathophysiology and Treatment of Non-motor Dysfunction in Amyotrophic Lateral Sclerosis. Cns Drugs. PMID 33993457 DOI: 10.1007/s40263-021-00820-1 |
0.345 |
|
| 2021 |
McMackin R, Dukic S, Costello E, Pinto-Grau M, McManus L, Broderick M, Chipika R, Iyer PM, Heverin M, Bede P, Muthuraman M, Pender N, Hardiman O, Nasseroleslami B. Cognitive network hyperactivation and motor cortex decline correlate with ALS prognosis. Neurobiology of Aging. 104: 57-70. PMID 33964609 DOI: 10.1016/j.neurobiolaging.2021.03.002 |
0.798 |
|
| 2021 |
Finegan E, Shing SLH, Chipika RH, Chang KM, McKenna MC, Doherty MA, Hengeveld JC, Vajda A, Pender N, Donaghy C, Hutchinson S, McLaughlin RL, Hardiman O, Bede P. Extra-motor cerebral changes and manifestations in primary lateral sclerosis. Brain Imaging and Behavior. PMID 33409820 DOI: 10.1007/s11682-020-00421-4 |
0.363 |
|
| 2021 |
McMackin R, Dukic S, Costello E, Pinto-Grau M, Keenan O, Fasano A, Buxo T, Heverin M, Reilly RB, Pender N, Hardiman O, Nasseroleslami B. Sustained attention to response task-related beta oscillations relate to performance and provide a functional biomarker in ALS. Journal of Neural Engineering. PMID 33395671 DOI: 10.1088/1741-2552/abd829 |
0.785 |
|
| 2020 |
Coffey A, Bista S, Fasano A, Buxo T, Mitchell M, Giglia ER, Dukic S, Fenech M, Barry M, Wade A, Heverin M, Muthuraman M, Carson RG, Lowery M, Hardiman O, et al. Altered supraspinal motor networks in survivors of poliomyelitis: A cortico-muscular coherence study. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 132: 106-113. PMID 33271481 DOI: 10.1016/j.clinph.2020.10.011 |
0.678 |
|
| 2020 |
Finegan E, Siah WF, Shing SLH, Chipika RH, Chang KM, McKenna MC, Doherty MA, Hengeveld JC, Vajda A, Donaghy C, Hutchinson S, McLaughlin RL, Hardiman O, Bede P. Imaging and clinical data indicate considerable disease burden in 'probable' PLS: Patients with UMN symptoms for 2-4 years. Data in Brief. 32: 106247. PMID 32944602 DOI: 10.1016/J.Dib.2020.106247 |
0.368 |
|
| 2020 |
Chipika RH, Siah WF, Shing SLH, Finegan E, McKenna MC, Christidi F, Chang KM, Karavasilis E, Vajda A, Hengeveld JC, Doherty MA, Donaghy C, Hutchinson S, McLaughlin RL, Hardiman O, et al. MRI data confirm the selective involvement of thalamic and amygdalar nuclei in amyotrophic lateral sclerosis and primary lateral sclerosis. Data in Brief. 32: 106246. PMID 32944601 DOI: 10.1016/J.Dib.2020.106246 |
0.444 |
|
| 2020 |
Pender N, Pinto-Grau M, Hardiman O. Cognitive and behavioural impairment in amyotrophic lateral sclerosis. Current Opinion in Neurology. 33: 649-654. PMID 32833751 DOI: 10.1097/Wco.0000000000000862 |
0.348 |
|
| 2020 |
Finegan E, Li Hi Shing S, Siah WF, Chipika RH, Chang KM, McKenna MC, Doherty MA, Hengeveld JC, Vajda A, Donaghy C, Hutchinson S, McLaughlin RL, Hardiman O, Bede P. Evolving diagnostic criteria in primary lateral sclerosis: The clinical and radiological basis of "probable PLS". Journal of the Neurological Sciences. 417: 117052. PMID 32731060 DOI: 10.1016/J.Jns.2020.117052 |
0.358 |
|
| 2020 |
Chipika RH, Christidi F, Finegan E, Li Hi Shing S, McKenna MC, Chang KM, Karavasilis E, Doherty MA, Hengeveld JC, Vajda A, Pender N, Hutchinson S, Donaghy C, McLaughlin RL, Hardiman O, et al. Amygdala pathology in amyotrophic lateral sclerosis and primary lateral sclerosis. Journal of the Neurological Sciences. 117039. PMID 32713609 DOI: 10.1016/J.Jns.2020.117039 |
0.432 |
|
| 2020 |
van Eijk RPA, Kliest T, McDermott CJ, Roes KCB, Van Damme P, Chio A, Weber M, Ingre C, Corcia P, Povedano M, Reviers E, van Es MA, Al-Chalabi A, Hardiman O, van den Berg LH. TRICALS: creating a highway toward a cure. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-6. PMID 32643415 DOI: 10.1080/21678421.2020.1788092 |
0.316 |
|
| 2020 |
Hardiman O, van den Berg LH. The Beginning of Genomic Therapies for ALS. The New England Journal of Medicine. 383: 180-181. PMID 32640137 DOI: 10.1056/Nejme2012930 |
0.417 |
|
| 2020 |
Franklin JP, Cooper-Knock J, Baheerathan A, Moll T, Männikkö R, Heverin M, Hardiman O, Shaw PJ, Hanna MG. Concurrent sodium channelopathies and amyotrophic lateral sclerosis supports shared pathogenesis. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-4. PMID 32619119 DOI: 10.1080/21678421.2020.1786128 |
0.371 |
|
| 2020 |
Bendotti C, Bonetto V, Pupillo E, Logroscino G, Al-Chalabi A, Lunetta C, Riva N, Mora G, Lauria G, Weishaupt JH, Agosta F, Malaspina A, Basso M, Greensmith L, Van Den Bosch L, ... ... Hardiman O, et al. Focus on the heterogeneity of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-11. PMID 32583689 DOI: 10.1080/21678421.2020.1779298 |
0.44 |
|
| 2020 |
Chipika RH, Finegan E, Li Hi Shing S, McKenna MC, Christidi F, Chang KM, Doherty MA, Hengeveld JC, Vajda A, Pender N, Hutchinson S, Donaghy C, McLaughlin RL, Hardiman O, Bede P. "Switchboard" malfunction in motor neuron diseases: Selective pathology of thalamic nuclei in amyotrophic lateral sclerosis and primary lateral sclerosis. Neuroimage. Clinical. 27: 102300. PMID 32554322 DOI: 10.1016/J.Nicl.2020.102300 |
0.481 |
|
| 2020 |
Burke T, Pinto-Grau M, Costello E, Peelo C, Lonergan K, Heverin M, Hardiman O, Pender N. The reading the mind in the eyes test short form (A & B): validation and outcomes in an amyotrophic lateral sclerosis cohort. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-9. PMID 32501122 DOI: 10.1080/21678421.2020.1772824 |
0.337 |
|
| 2020 |
McMackin R, Dukic S, Costello E, Pinto-Grau M, Fasano A, Buxo T, Heverin M, Reilly R, Muthuraman M, Pender N, Hardiman O, Nasseroleslami B. Corrigendum to: Localization of Brain Networks Engaged by the Sustained Attention to Response Task Provides Quantitative Markers of Executive Impairment in Amyotrophic Lateral Sclerosis. Cerebral Cortex (New York, N.Y. : 1991). PMID 32436562 DOI: 10.1093/cercor/bhaa152 |
0.787 |
|
| 2020 |
Brizzi KT, Bridges JFP, Yersak J, Balas C, Thakur N, Galvin M, Hardiman O, Heatwole C, Ravits J, Simmons Z, Bruijn L, Chan J, Bedlack R, Berry JD. Understanding the needs of people with ALS: a national survey of patients and caregivers. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-9. PMID 32396393 DOI: 10.1080/21678421.2020.1760889 |
0.336 |
|
| 2020 |
Shefner JM, Al-Chalabi A, Baker MR, Cui LY, de Carvalho M, Eisen A, Grosskreutz J, Hardiman O, Henderson R, Manuel Matamala J, Mitsumoto H, Paulus W, Simon N, Swash M, Talbot K, et al. A proposal for new diagnostic criteria for ALS. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. PMID 32387049 DOI: 10.1016/J.Clinph.2020.04.005 |
0.328 |
|
| 2020 |
McMackin R, Dukic S, Costello E, Pinto-Grau M, Fasano A, Buxo T, Heverin M, Reilly R, Muthuraman M, Pender N, Hardiman O, Nasseroleslami B. Localization of Brain Networks Engaged by the Sustained Attention to Response Task Provides Quantitative Markers of Executive Impairment in Amyotrophic Lateral Sclerosis. Cerebral Cortex (New York, N.Y. : 1991). PMID 32318719 DOI: 10.1093/Cercor/Bhaa076 |
0.799 |
|
| 2020 |
Antoniadi AM, Galvin M, Heverin M, Hardiman O, Mooney C. Prediction of caregiver burden in amyotrophic lateral sclerosis: a machine learning approach using random forests applied to a cohort study. Bmj Open. 10: e033109. PMID 32114464 DOI: 10.1136/Bmjopen-2019-033109 |
0.381 |
|
| 2020 |
Bede P, Chipika RH, Finegan E, Li Hi Shing S, Chang KM, Doherty MA, Hengeveld JC, Vajda A, Hutchinson S, Donaghy C, McLaughlin RL, Hardiman O. Progressive brainstem pathology in motor neuron diseases: Imaging data from amyotrophic lateral sclerosis and primary lateral sclerosis. Data in Brief. 29: 105229. PMID 32083157 DOI: 10.1016/J.Dib.2020.105229 |
0.418 |
|
| 2020 |
Meier JM, van der Burgh HK, Nitert AD, Bede P, de Lange SC, Hardiman O, van den Berg LH, van den Heuvel MP. Connectome-based propagation model in amyotrophic lateral sclerosis. Annals of Neurology. PMID 32072667 DOI: 10.1002/Ana.25706 |
0.419 |
|
| 2020 |
Finegan E, Hi Shing SL, Chipika RH, McKenna MC, Doherty MA, Hengeveld JC, Vajda A, Donaghy C, McLaughlin RL, Hutchinson S, Hardiman O, Bede P. Thalamic, hippocampal and basal ganglia pathology in primary lateral sclerosis and amyotrophic lateral sclerosis: Evidence from quantitative imaging data. Data in Brief. 29: 105115. PMID 32055654 DOI: 10.1016/J.Dib.2020.105115 |
0.361 |
|
| 2019 |
Costello E, Lonergan K, Madden C, O'Sullivan M, Mays I, Heverin M, Pinto-Grau M, Hardiman O, Pender N. Equivalency and practice effects of alternative versions of the Edinburgh Cognitive and Behavioral ALS Screen (ECAS). Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-6. PMID 31833401 DOI: 10.1080/21678421.2019.1701681 |
0.31 |
|
| 2019 |
Tattersall R, Murray D, Heverin M, Rooney J, Tobin K, Vance R, Hardiman O, Meldrum D. Respiratory measurements and airway clearance device prescription over one year in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-8. PMID 31823661 DOI: 10.1080/21678421.2019.1697887 |
0.317 |
|
| 2019 |
Finegan E, Li Hi Shing S, Chipika RH, Doherty MA, Hengeveld JC, Vajda A, Donaghy C, Pender N, McLaughlin RL, Hardiman O, Bede P. Widespread subcortical grey matter degeneration in primary lateral sclerosis: a multimodal imaging study with genetic profiling. Neuroimage. Clinical. 24: 102089. PMID 31795059 DOI: 10.1016/J.Nicl.2019.102089 |
0.456 |
|
| 2019 |
Bede P, Chipika RH, Finegan E, Li Hi Shing S, Doherty MA, Hengeveld JC, Vajda A, Hutchinson S, Donaghy C, McLaughlin RL, Hardiman O. Brainstem pathology in amyotrophic lateral sclerosis and primary lateral sclerosis: A longitudinal neuroimaging study. Neuroimage. Clinical. 24: 102054. PMID 31711033 DOI: 10.1016/J.Nicl.2019.102054 |
0.458 |
|
| 2019 |
Burke T, Wilson O'Raghallaigh J, Maguire S, Galvin M, Heverin M, Hardiman O, Pender N. Group interventions for amyotrophic lateral sclerosis caregivers in Ireland: a randomised controlled trial protocol. Bmj Open. 9: e030684. PMID 31542756 DOI: 10.1136/Bmjopen-2019-030684 |
0.397 |
|
| 2019 |
Peters S, Visser AE, D'Ovidio F, Vlaanderen J, Portengen L, Beghi E, Chio A, Logroscino G, Hardiman O, Pupillo E, Veldink JH, Vermeulen R, van den Berg LH. Effect modification of the association between total cigarette smoking and ALS risk by intensity, duration and time-since-quitting: Euro-MOTOR. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 31434759 DOI: 10.1136/Jnnp-2019-320986 |
0.324 |
|
| 2019 |
Li Hi Shing S, Chipika RH, Finegan E, Murray D, Hardiman O, Bede P. Post-polio Syndrome: More Than Just a Lower Motor Neuron Disease. Frontiers in Neurology. 10: 773. PMID 31379723 DOI: 10.3389/Fneur.2019.00773 |
0.346 |
|
| 2019 |
Dukic S, McMackin R, Buxo T, Fasano A, Chipika R, Pinto-Grau M, Costello E, Schuster C, Hammond M, Heverin M, Coffey A, Broderick M, Iyer PM, Mohr K, Gavin B, ... ... Hardiman O, et al. Patterned functional network disruption in amyotrophic lateral sclerosis. Human Brain Mapping. PMID 31348605 DOI: 10.1002/Hbm.24740 |
0.826 |
|
| 2019 |
Ryan M, Heverin M, McLaughlin RL, Hardiman O. Lifetime Risk and Heritability of Amyotrophic Lateral Sclerosis. Jama Neurology. PMID 31329211 DOI: 10.1001/Jamaneurol.2019.2044 |
0.313 |
|
| 2019 |
Finegan E, Chipika RH, Li Hi Shing S, Doherty MA, Hengeveld JC, Vajda A, Donaghy C, McLaughlin RL, Pender N, Hardiman O, Bede P. The clinical and radiological profile of primary lateral sclerosis: a population-based study. Journal of Neurology. PMID 31325016 DOI: 10.1007/S00415-019-09473-Z |
0.435 |
|
| 2019 |
Al-Chalabi A, Shaw P, Leigh PN, van den Berg L, Hardiman O, Ludolph A, Aho VV, Sarapohja T, Kuoppamäki M. Oral levosimendan in amyotrophic lateral sclerosis: a phase II multicentre, randomised, double-blind, placebo-controlled trial. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 31315908 DOI: 10.1136/Jnnp-2018-320288 |
0.309 |
|
| 2019 |
Murray D, Rooney J, Campion A, Fenton L, Hammond M, Heverin M, Meldrum D, Moloney H, Tattersall R, Hardiman O. Longitudinal analysis of sniff nasal inspiratory pressure assessed using occluded and un-occluded measurement techniques in amyotrophic lateral sclerosis and primary lateral sclerosis. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-9. PMID 31313597 DOI: 10.1080/21678421.2019.1639194 |
0.371 |
|
| 2019 |
Dekker AM, Diekstra FP, Pulit SL, Tazelaar GHP, van der Spek RA, van Rheenen W, van Eijk KR, Calvo A, Brunetti M, Damme PV, Robberecht W, Hardiman O, McLaughlin R, Chiò A, Sendtner M, et al. Exome array analysis of rare and low frequency variants in amyotrophic lateral sclerosis. Scientific Reports. 9: 5931. PMID 30976013 DOI: 10.1038/S41598-019-42091-3 |
0.344 |
|
| 2019 |
van Eijk RPA, Rooney J, Hardiman O, van den Berg LH. Two heads are better than one: benefits of joint models for ALS trials. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 30975822 DOI: 10.1136/Jnnp-2019-320553 |
0.344 |
|
| 2019 |
Finegan E, Chipika RH, Li Hi Shing S, Hardiman O, Bede P. Pathological Crying and Laughing in Motor Neuron Disease: Pathobiology, Screening, Intervention. Frontiers in Neurology. 10: 260. PMID 30949121 DOI: 10.3389/Fneur.2019.00260 |
0.414 |
|
| 2019 |
Chipika RH, Finegan E, Li Hi Shing S, Hardiman O, Bede P. Tracking a Fast-Moving Disease: Longitudinal Markers, Monitoring, and Clinical Trial Endpoints in ALS. Frontiers in Neurology. 10: 229. PMID 30941088 DOI: 10.3389/Fneur.2019.00229 |
0.415 |
|
| 2019 |
Ryan M, Zaldívar Vaillant T, McLaughlin RL, Doherty MA, Rooney J, Heverin M, Gutierrez J, Lara-Fernández GE, Pita Rodríguez M, Hackembruch J, Perna A, Vazquez MC, Musio M, Ketzoian CN, Logroscino G, ... Hardiman O, et al. Comparison of the clinical and genetic features of amyotrophic lateral sclerosis across Cuban, Uruguayan and Irish clinic-based populations. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 30846540 DOI: 10.1136/Jnnp-2018-319838 |
0.334 |
|
| 2019 |
Cooper-Knock J, Moll T, Ramesh T, Castelli L, Beer A, Robins H, Fox I, Niedermoser I, Van Damme P, Moisse M, Robberecht W, Hardiman O, Panades MP, Assialioui A, Mora JS, et al. Mutations in the Glycosyltransferase Domain of GLT8D1 Are Associated with Familial Amyotrophic Lateral Sclerosis. Cell Reports. 26: 2298-2306.e5. PMID 30811981 DOI: 10.1016/J.Celrep.2019.02.006 |
0.35 |
|
| 2019 |
McMackin R, Muthuraman M, Groppa S, Babiloni C, Taylor JP, Kiernan MC, Nasseroleslami B, Hardiman O. Measuring network disruption in neurodegenerative diseases: New approaches using signal analysis. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 30760643 DOI: 10.1136/Jnnp-2018-319581 |
0.814 |
|
| 2019 |
McMackin R, Bede P, Pender N, Hardiman O, Nasseroleslami B. Neurophysiological markers of network dysfunction in neurodegenerative diseases. Neuroimage. Clinical. 22: 101706. PMID 30738372 DOI: 10.1016/J.Nicl.2019.101706 |
0.788 |
|
| 2019 |
McMackin R, Dukic S, Broderick M, Iyer PM, Pinto-Grau M, Mohr K, Chipika R, Coffey A, Buxo T, Schuster C, Gavin B, Heverin M, Bede P, Pender N, Lalor EC, ... ... Hardiman O, et al. Dysfunction of attention switching networks in amyotrophic lateral sclerosis. Neuroimage. Clinical. 22: 101707. PMID 30735860 DOI: 10.1016/J.Nicl.2019.101707 |
0.81 |
|
| 2019 |
Kueffner R, Zach N, Bronfeld M, Norel R, Atassi N, Balagurusamy V, Di Camillo B, Chio A, Cudkowicz M, Dillenberger D, Garcia-Garcia J, Hardiman O, Hoff B, Knight J, Leitner ML, et al. Stratification of amyotrophic lateral sclerosis patients: a crowdsourcing approach. Scientific Reports. 9: 690. PMID 30679616 DOI: 10.1038/S41598-018-36873-4 |
0.352 |
|
| 2019 |
Finegan E, Chipika RH, Shing SLH, Hardiman O, Bede P. Primary lateral sclerosis: a distinct entity or part of the ALS spectrum? Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-13. PMID 30654671 DOI: 10.1080/21678421.2018.1550518 |
0.463 |
|
| 2019 |
Peters S, Visser AE, D'Ovidio F, Beghi E, Chiò A, Logroscino G, Hardiman O, Kromhout H, Huss A, Veldink J, Vermeulen R, van den Berg LH. Electric Shock and Extremely Low-Frequency Magnetic Field Exposure and the Risk of ALS: Euro-MOTOR. American Journal of Epidemiology. PMID 30649156 DOI: 10.1093/Aje/Kwy287 |
0.316 |
|
| 2018 |
Hardiman O. Global burden of motor neuron diseases: mind the gaps. The Lancet. Neurology. PMID 30409708 DOI: 10.1016/S1474-4422(18)30398-3 |
0.374 |
|
| 2018 |
Tazelaar GHP, Dekker AM, van Vugt JJFA, van der Spek RA, Westeneng HJ, Kool LJBG, Kenna KP, van Rheenen W, Pulit SL, McLaughlin RL, Sproviero W, Iacoangeli A, Hübers A, Brenner D, Morrison KE, ... ... Hardiman O, et al. Association of NIPA1 repeat expansions with amyotrophic lateral sclerosis in a large international cohort. Neurobiology of Aging. PMID 30342764 DOI: 10.1016/J.Neurobiolaging.2018.09.012 |
0.398 |
|
| 2018 |
Crockford C, Newton J, Lonergan K, Chiwera T, Booth T, Chandran S, Colville S, Heverin M, Mays I, Pal S, Pender N, Pinto-Grau M, Radakovic R, Shaw CE, Stephenson L, ... ... Hardiman O, et al. ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS. Neurology. PMID 30209236 DOI: 10.1212/Wnl.0000000000006317 |
0.381 |
|
| 2018 |
D'Ovidio F, Rooney JPK, Visser AE, Manera U, Beghi E, Logroscino G, Vermeulen RCH, Veldink JH, van den Berg LH, Hardiman O, Chiò A. Association between alcohol exposure and the risk of amyotrophic lateral sclerosis in the Euro-MOTOR study. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 30076269 DOI: 10.1136/Jnnp-2018-318559 |
0.345 |
|
| 2018 |
Chiò A, Mazzini L, D'Alfonso S, Corrado L, Canosa A, Moglia C, Manera U, Bersano E, Brunetti M, Barberis M, Veldink JH, van den Berg LH, Pearce N, Sproviero W, McLaughlin R, ... ... Hardiman O, et al. The multistep hypothesis of ALS revisited: The role of genetic mutations. Neurology. PMID 30045958 DOI: 10.1212/Wnl.0000000000005996 |
0.345 |
|
| 2018 |
Ryan M, Heverin M, Doherty MA, Davis N, Corr EM, Vajda A, Pender N, McLaughlin R, Hardiman O. Determining the incidence of familiality in ALS: A study of temporal trends in Ireland from 1994 to 2016. Neurology. Genetics. 4: e239. PMID 29845113 DOI: 10.1212/Nxg.0000000000000239 |
0.31 |
|
| 2018 |
Pinto-Grau M, Hardiman O, Pender N. The Study of Language in the Amyotrophic Lateral Sclerosis - Frontotemporal Spectrum Disorder: a Systematic Review of Findings and New Perspectives. Neuropsychology Review. PMID 29705950 DOI: 10.1007/S11065-018-9375-7 |
0.41 |
|
| 2018 |
Visser AE, Rooney JPK, D'Ovidio F, Westeneng HJ, Vermeulen RCH, Beghi E, Chiò A, Logroscino G, Hardiman O, Veldink JH, van den Berg LH. Multicentre, cross-cultural, population-based, case-control study of physical activity as risk factor for amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 29685899 DOI: 10.1136/Jnnp-2017-317724 |
0.308 |
|
| 2018 |
Heiman-Patterson TD, Cudkowicz ME, De Carvalho M, Genge A, Hardiman O, Jackson CE, Lechtzin N, Mitsumoto H, Silani V, Andrews JA, Chen D, Kulke S, Rudnicki SA, van den Berg LH. Understanding the use of NIV in ALS: results of an international ALS specialist survey. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-11. PMID 29661084 DOI: 10.1080/21678421.2018.1457058 |
0.361 |
|
| 2018 |
Logroscino G, Marin B, Piccininni M, Arcuti S, Chiò A, Hardiman O, Rooney J, Zoccolella S, Couratier P, Preux PM, Beghi E. Referral bias in ALS epidemiological studies. Plos One. 13: e0195821. PMID 29659621 DOI: 10.1371/Journal.Pone.0195821 |
0.377 |
|
| 2018 |
Westeneng HJ, Debray TPA, Visser AE, van Eijk RPA, Rooney JPK, Calvo A, Martin S, McDermott CJ, Thompson AG, Pinto S, Kobeleva X, Rosenbohm A, Stubendorff B, Sommer H, Middelkoop BM, ... ... Hardiman O, et al. Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model. The Lancet. Neurology. PMID 29598923 DOI: 10.1016/S1474-4422(18)30089-9 |
0.383 |
|
| 2018 |
Nicolas A, Kenna KP, Renton AE, Ticozzi N, Faghri F, Chia R, Dominov JA, Kenna BJ, Nalls MA, Keagle P, Rivera AM, van Rheenen W, Murphy NA, van Vugt JJFA, Geiger JT, ... ... Hardiman O, et al. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene. Neuron. 97: 1268-1283.e6. PMID 29566793 DOI: 10.1016/J.Neuron.2018.02.027 |
0.384 |
|
| 2018 |
Lechtzin N, Cudkowicz ME, de Carvalho M, Genge A, Hardiman O, Mitsumoto H, Mora JS, Shefner J, Van den Berg LH, Andrews JA. Respiratory measures in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-10. PMID 29566571 DOI: 10.1080/21678421.2018.1452945 |
0.329 |
|
| 2018 |
Bede P, Omer T, Finegan E, Chipika RH, Iyer PM, Doherty MA, Vajda A, Pender N, McLaughlin RL, Hutchinson S, Hardiman O. Connectivity-based characterisation of subcortical grey matter pathology in frontotemporal dementia and ALS: a multimodal neuroimaging study. Brain Imaging and Behavior. PMID 29423814 DOI: 10.1007/S11682-018-9837-9 |
0.47 |
|
| 2018 |
Andrews JA, Cudkowicz ME, Hardiman O, Meng L, Bian A, Lee J, Wolff AA, Malik FI, Shefner JM. VITALITY-ALS, a phase III trial of tirasemtiv, a selective fast skeletal muscle troponin activator, as a potential treatment for patients with amyotrophic lateral sclerosis: study design and baseline characteristics. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-8. PMID 29402141 DOI: 10.1080/21678421.2018.1426770 |
0.325 |
|
| 2018 |
Burke T, Hardiman O, Pinto-Grau M, Lonergan K, Heverin M, Tobin K, Staines A, Galvin M, Pender N. Longitudinal predictors of caregiver burden in amyotrophic lateral sclerosis: a population-based cohort of patient-caregiver dyads. Journal of Neurology. PMID 29396678 DOI: 10.1007/S00415-018-8770-6 |
0.366 |
|
| 2018 |
Galvin M, Carney S, Corr B, Mays I, Pender N, Hardiman O. Needs of informal caregivers across the caregiving course in amyotrophic lateral sclerosis: a qualitative analysis. Bmj Open. 8: e018721. PMID 29374665 DOI: 10.1136/Bmjopen-2017-018721 |
0.361 |
|
| 2017 |
Van Der Spek RA, Van Rheenen W, Pulit SL, Kenna KP, Ticozzi N, Kooyman M, McLaughlin RL, Moisse M, Van Eijk KR, Van Vugt JJFA, Andersen P, Nazli Basak A, Blair I, De Carvalho M, Chio A, ... ... Hardiman O, et al. Reconsidering the causality of TIA1 mutations in ALS. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-3. PMID 29235362 DOI: 10.1080/21678421.2017.1413118 |
0.313 |
|
| 2017 |
Bede P, Hardiman O. Longitudinal structural changes in ALS: a three time-point imaging study of white and gray matter degeneration. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-10. PMID 29214883 DOI: 10.1080/21678421.2017.1407795 |
0.325 |
|
| 2017 |
Crockford C, Newton J, Lonergan K, Madden C, Mays I, O'Sullivan M, Costello E, Pinto-Grau M, Vajda A, Heverin M, Pender N, Al-Chalabi A, Hardiman O, Abrahams S. Measuring reliable change in cognition using the Edinburgh Cognitive and Behavioural ALS Screen (ECAS). Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-9. PMID 29214872 DOI: 10.1080/21678421.2017.1407794 |
0.375 |
|
| 2017 |
Crockford CJ, Kleynhans M, Wilton E, Radakovic R, Newton J, Niven EH, Al-Chalabi A, Hardiman O, Bak TH, Abrahams S. ECAS A-B-C: alternate forms of the Edinburgh Cognitive and Behavioural ALS Screen. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-8. PMID 29205065 DOI: 10.1080/21678421.2017.1407793 |
0.361 |
|
| 2017 |
Nasseroleslami B, Dukic S, Broderick M, Mohr K, Schuster C, Gavin B, McLaughlin R, Heverin M, Vajda A, Iyer PM, Pender N, Bede P, Lalor EC, Hardiman O. Characteristic Increases in EEG Connectivity Correlate With Changes of Structural MRI in Amyotrophic Lateral Sclerosis. Cerebral Cortex (New York, N.Y. : 1991). 1-15. PMID 29136131 DOI: 10.1093/Cercor/Bhx301 |
0.826 |
|
| 2017 |
Pupillo E, Poloni M, Bianchi E, Giussani G, Logroscino G, Zoccolella S, Chiò A, Calvo A, Corbo M, Lunetta C, Marin B, Mitchell D, Hardiman O, Rooney J, Stevic Z, et al. Trauma and amyotrophic lateral sclerosis: a european population-based case-control study from the EURALS consortium. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-8. PMID 29063790 DOI: 10.1080/21678421.2017.1386687 |
0.316 |
|
| 2017 |
Dukic S, Iyer PM, Mohr K, Hardiman O, Lalor EC, Nasseroleslami B. Estimation of coherence using the median is robust against EEG artefacts. Conference Proceedings : ... Annual International Conference of the Ieee Engineering in Medicine and Biology Society. Ieee Engineering in Medicine and Biology Society. Annual Conference. 2017: 3949-3952. PMID 29060761 DOI: 10.1109/EMBC.2017.8037720 |
0.756 |
|
| 2017 |
O'Brien M, Burke T, Heverin M, Vajda A, McLaughlin R, Gibbons J, Byrne S, Pinto-Grau M, Elamin M, Pender N, Hardiman O. Clustering of Neuropsychiatric Disease in First-Degree and Second-Degree Relatives of Patients With Amyotrophic Lateral Sclerosis. Jama Neurology. PMID 29049464 DOI: 10.1001/Jamaneurol.2017.2699 |
0.405 |
|
| 2017 |
Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, Shaw PJ, Simmons Z, van den Berg LH. Amyotrophic lateral sclerosis. Nature Reviews. Disease Primers. 3: 17071. PMID 28980624 DOI: 10.1038/nrdp.2017.71 |
0.332 |
|
| 2017 |
Armon C, Hardiman O. The beginning of precision medicine in ALS? Treatment to fit the genes. Neurology. PMID 28978653 DOI: 10.1212/Wnl.0000000000004612 |
0.417 |
|
| 2017 |
Al-Chalabi A, Andersen PM, Chandran S, Chio A, Corcia P, Couratier P, Danielsson O, de Carvalho M, Desnuelle C, Grehl T, Grosskreutz J, Holmøy T, Ingre C, Karlsborg M, Kleveland G, ... ... Hardiman O, et al. July 2017 ENCALS statement on edaravone. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-4. PMID 28975816 DOI: 10.1080/21678421.2017.1369125 |
0.405 |
|
| 2017 |
Iyer PM, Mohr K, Broderick M, Gavin B, Burke T, Bede P, Pinto-Grau M, Pender NP, McLaughlin R, Vajda A, Heverin M, Lalor EC, Hardiman O, Nasseroleslami B. Mismatch Negativity as an Indicator of Cognitive Sub-Domain Dysfunction in Amyotrophic Lateral Sclerosis. Frontiers in Neurology. 8: 395. PMID 28861032 DOI: 10.3389/Fneur.2017.00395 |
0.801 |
|
| 2017 |
Rooney JPK, Visser AE, D'Ovidio F, Vermeulen R, Beghi E, Chio A, Veldink JH, Logroscino G, van den Berg LH, Hardiman O. A case-control study of hormonal exposures as etiologic factors for ALS in women: Euro-MOTOR. Neurology. PMID 28835399 DOI: 10.1212/Wnl.0000000000004390 |
0.359 |
|
| 2017 |
Bede P, Iyer PM, Finegan E, Omer T, Hardiman O. Virtual brain biopsies in amyotrophic lateral sclerosis: Diagnostic classification based on in vivo pathological patterns. Neuroimage. Clinical. 15: 653-658. PMID 28664036 DOI: 10.1016/J.Nicl.2017.06.010 |
0.336 |
|
| 2017 |
Turner MR, Al-Chalabi A, Chio A, Hardiman O, Kiernan MC, Rohrer JD, Rowe J, Seeley W, Talbot K. Genetic screening in sporadic ALS and FTD. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 28642287 DOI: 10.1136/Jnnp-2017-315995 |
0.324 |
|
| 2017 |
Galvin M, Ryan P, Maguire S, Heverin M, Madden C, Vajda A, Normand C, Hardiman O. The path to specialist multidisciplinary care in amyotrophic lateral sclerosis: A population- based study of consultations, interventions and costs. Plos One. 12: e0179796. PMID 28640860 DOI: 10.1371/Journal.Pone.0179796 |
0.371 |
|
| 2017 |
Madill M, McDonagh K, Ma J, Vajda A, McLoughlin P, O'Brien T, Hardiman O, Shen S. Amyotrophic lateral sclerosis patient iPSC-derived astrocytes impair autophagy via non-cell autonomous mechanisms. Molecular Brain. 10: 22. PMID 28610619 DOI: 10.1186/S13041-017-0300-4 |
0.369 |
|
| 2017 |
Pinto-Grau M, Costello E, O'Connor S, Elamin M, Burke T, Heverin M, Pender N, Hardiman O. Assessing behavioural changes in ALS: cross-validation of ALS-specific measures. Journal of Neurology. PMID 28600595 DOI: 10.1007/S00415-017-8536-6 |
0.384 |
|
| 2017 |
D'Ovidio F, Rooney JPK, Visser AE, Vermeulen RCH, Veldink JH, Van Den Berg LH, Hardiman O, Logroscino G, Chiò A, Beghi E. Critical issues in ALS case-control studies: the case of the Euro-MOTOR study. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-8. PMID 28594593 DOI: 10.1080/21678421.2017.1285939 |
0.393 |
|
| 2017 |
Omer T, Finegan E, Hutchinson S, Doherty M, Vajda A, McLaughlin RL, Pender N, Hardiman O, Bede P. Neuroimaging patterns along the ALS-FTD spectrum: a multiparametric imaging study. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-13. PMID 28562080 DOI: 10.1080/21678421.2017.1332077 |
0.433 |
|
| 2017 |
Hardiman O, van den Berg LH. Edaravone: a new treatment for ALS on the horizon? The Lancet. Neurology. PMID 28522180 DOI: 10.1016/S1474-4422(17)30163-1 |
0.327 |
|
| 2017 |
Burke T, Pinto-Grau M, Lonergan K, Bede P, O'Sullivan M, Heverin M, Vajda A, McLaughlin RL, Pender N, Hardiman O. A Cross-sectional population-based investigation into behavioral change in amyotrophic lateral sclerosis: subphenotypes, staging, cognitive predictors, and survival. Annals of Clinical and Translational Neurology. 4: 305-317. PMID 28491898 DOI: 10.1002/Acn3.407 |
0.315 |
|
| 2017 |
Smith BN, Topp SD, Fallini C, Shibata H, Chen HJ, Troakes C, King A, Ticozzi N, Kenna KP, Soragia-Gkazi A, Miller JW, Sato A, Dias DM, Jeon M, Vance C, ... ... Hardiman O, et al. Mutations in the vesicular trafficking protein annexin A11 are associated with amyotrophic lateral sclerosis. Science Translational Medicine. 9. PMID 28469040 DOI: 10.1126/Scitranslmed.Aad9157 |
0.316 |
|
| 2017 |
Schuster C, Hardiman O, Bede P. Survival prediction in Amyotrophic lateral sclerosis based on MRI measures and clinical characteristics. Bmc Neurology. 17: 73. PMID 28412941 DOI: 10.1186/S12883-017-0854-X |
0.341 |
|
| 2017 |
McLaughlin RL, Schijven D, van Rheenen W, van Eijk KR, O'Brien M, Kahn RS, Ophoff RA, Goris A, Bradley DG, Al-Chalabi A, van den Berg LH, Luykx JJ, Hardiman O, Veldink JH, et al. Genetic correlation between amyotrophic lateral sclerosis and schizophrenia. Nature Communications. 8: 14774. PMID 28322246 DOI: 10.1038/Ncomms14774 |
0.331 |
|
| 2017 |
Galvin M, Gaffney R, Corr B, Mays I, Hardiman O. From first symptoms to diagnosis of amyotrophic lateral sclerosis: perspectives of an Irish informal caregiver cohort-a thematic analysis. Bmj Open. 7: e014985. PMID 28320799 DOI: 10.1136/Bmjopen-2016-014985 |
0.311 |
|
| 2017 |
Hardiman O, Chalabi AA, Brayne C, Beghi E, van den Berg LH, Chio A, Martin S, Logroscino G, Rooney J. The changing picture of amyotrophic lateral sclerosis: lessons from European registers. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 28285264 DOI: 10.1136/Jnnp-2016-314495 |
0.349 |
|
| 2017 |
Burke T, Galvin M, Pinto-Grau M, Lonergan K, Madden C, Mays I, Carney S, Hardiman O, Pender N. Caregivers of patients with amyotrophic lateral sclerosis: investigating quality of life, caregiver burden, service engagement, and patient survival. Journal of Neurology. PMID 28280986 DOI: 10.1007/S00415-017-8448-5 |
0.338 |
|
| 2017 |
Vajda A, McLaughlin RL, Heverin M, Thorpe O, Abrahams S, Al-Chalabi A, Hardiman O. Genetic testing in ALS: A survey of current practices. Neurology. PMID 28159885 DOI: 10.1212/Wnl.0000000000003686 |
0.317 |
|
| 2017 |
Burke T, Lonergan K, Pinto-Grau M, Elamin M, Bede P, Madden C, Hardiman O, Pender N. Visual encoding, consolidation, and retrieval in amyotrophic lateral sclerosis: executive function as a mediator, and predictor of performance. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-9. PMID 28084080 DOI: 10.1080/21678421.2016.1272615 |
0.336 |
|
| 2017 |
Omer T, Nasseroleslami B, Molloy F, Mullins G, Hardiman O. Motor Unit Number Index (MUNIX) of six muscles: normal values and effects of age and gender F1000research. 6. DOI: 10.7490/F1000Research.1113611.1 |
0.781 |
|
| 2016 |
Schuster C, Hardiman O, Bede P. Development of an Automated MRI-Based Diagnostic Protocol for Amyotrophic Lateral Sclerosis Using Disease-Specific Pathognomonic Features: A Quantitative Disease-State Classification Study. Plos One. 11: e0167331. PMID 27907080 DOI: 10.1371/Journal.Pone.0167331 |
0.306 |
|
| 2016 |
Pinto-Grau M, Burke T, Lonergan K, McHugh C, Mays I, Madden C, Vajda A, Heverin M, Elamin M, Hardiman O, Pender N. Screening for cognitive dysfunction in ALS: validation of the Edinburgh Cognitive and Behavioural ALS Screen (ECAS) using age and education adjusted normative data. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-8. PMID 27894201 DOI: 10.1080/21678421.2016.1249887 |
0.375 |
|
| 2016 |
Elamin M, Pinto-Grau M, Burke T, Bede P, Rooney J, O'Sullivan M, Lonergan K, Kirby E, Quinlan E, Breen N, Vajda A, Heverin M, Pender N, Hardiman O. Identifying behavioural changes in ALS: Validation of the Beaumont Behavioural Inventory (BBI). Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-6. PMID 27894191 DOI: 10.1080/21678421.2016.1248976 |
0.428 |
|
| 2016 |
Rooney J, Fogh I, Westeneng HJ, Vajda A, McLaughlin R, Heverin M, Jones A, van Eijk R, Calvo A, Mazzini L, Shaw C, Morrison K, Shaw PJ, Robberecht W, Van Damme P, ... ... Hardiman O, et al. C9orf72 expansion differentially affects males with spinal onset amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 27663272 DOI: 10.1136/Jnnp-2016-314093 |
0.343 |
|
| 2016 |
Al-Chalabi A, Hardiman O, Kiernan MC, Chiò A, Rix-Brooks B, van den Berg LH. Amyotrophic lateral sclerosis: moving towards a new classification system. The Lancet. Neurology. 15: 1182-94. PMID 27647646 DOI: 10.1016/S1474-4422(16)30199-5 |
0.335 |
|
| 2016 |
Galvin M, Corr B, Madden C, Mays I, McQuillan R, Timonen V, Staines A, Hardiman O. Caregiving in ALS - a mixed methods approach to the study of Burden. Bmc Palliative Care. 15: 81. PMID 27596749 DOI: 10.1186/S12904-016-0153-0 |
0.311 |
|
| 2016 |
Burke T, Pinto-Grau M, Lonergan K, Elamin M, Bede P, Costello E, Hardiman O, Pender N. Measurement of Social Cognition in Amyotrophic Lateral Sclerosis: A Population Based Study. Plos One. 11: e0160850. PMID 27556398 DOI: 10.1371/Journal.Pone.0160850 |
0.371 |
|
| 2016 |
van Rheenen W, Shatunov A, Dekker AM, McLaughlin RL, Diekstra FP, Pulit SL, van der Spek RA, Võsa U, de Jong S, Robinson MR, Yang J, Fogh I, van Doormaal PT, Tazelaar GH, Koppers M, ... ... Hardiman O, et al. Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis. Nature Genetics. 48: 1043-8. PMID 27455348 DOI: 10.1038/Ng.3622 |
0.329 |
|
| 2016 |
Kenna KP, van Doormaal PT, Dekker AM, Ticozzi N, Kenna BJ, Diekstra FP, van Rheenen W, van Eijk KR, Jones AR, Keagle P, Shatunov A, Sproviero W, Smith BN, van Es MA, Topp SD, ... ... Hardiman O, et al. NEK1 variants confer susceptibility to amyotrophic lateral sclerosis. Nature Genetics. PMID 27455347 DOI: 10.1038/Ng.3626 |
0.375 |
|
| 2016 |
Tobin K, Gilthorpe MS, Rooney J, Heverin M, Vajda A, Staines A, Hardiman O. Age-period-cohort analysis of trends in amyotrophic lateral sclerosis incidence. Journal of Neurology. PMID 27372451 DOI: 10.1007/S00415-016-8215-Z |
0.383 |
|
| 2016 |
Fogh I, Lin K, Tiloca C, Rooney J, Gellera C, Diekstra FP, Ratti A, Shatunov A, van Es MA, Proitsi P, Jones A, Sproviero W, Chiò A, McLaughlin RL, Sorarù G, ... ... Hardiman O, et al. Association of a Locus in the CAMTA1 Gene With Survival in Patients With Sporadic Amyotrophic Lateral Sclerosis. Jama Neurology. PMID 27244217 DOI: 10.1001/Jamaneurol.2016.1114 |
0.327 |
|
| 2016 |
Schuster C, Elamin M, Hardiman O, Bede P. The segmental diffusivity profile of amyotrophic lateral sclerosis associated white matter degeneration. European Journal of Neurology. 23: 1361-1371. PMID 27207250 DOI: 10.1111/Ene.13038 |
0.344 |
|
| 2016 |
Burke T, Elamin M, Bede P, Pinto-Grau M, Lonergan K, Hardiman O, Pender N. Discordant performance on the 'Reading the Mind in the Eyes' Test, based on disease onset in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-6. PMID 27152765 DOI: 10.1080/21678421.2016.1177088 |
0.397 |
|
| 2016 |
Rooney J, Heverin M, Vajda A, Burke T, Galvin M, Tobin K, Elamin M, Staines A, Hardiman O. Survival analysis of geospatial factors in the Irish ALS cohort. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-6. PMID 27145090 DOI: 10.1080/21678421.2016.1179326 |
0.376 |
|
| 2016 |
Bede P, Iyer PM, Schuster C, Elamin M, Mclaughlin RL, Kenna K, Hardiman O. The selective anatomical vulnerability of ALS: 'disease-defining' and 'disease-defying' brain regions. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-10. PMID 27087114 DOI: 10.3109/21678421.2016.1173702 |
0.38 |
|
| 2016 |
Williams KL, Topp S, Yang S, Smith B, Fifita JA, Warraich ST, Zhang KY, Farrawell N, Vance C, Hu X, Chesi A, Leblond CS, Lee A, Rayner SL, Sundaramoorthy V, ... ... Hardiman O, et al. CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia. Nature Communications. 7: 11253. PMID 27080313 DOI: 10.1038/Ncomms11253 |
0.356 |
|
| 2016 |
Janssens AI, Ruytings M, Al-Chalabi A, Chio A, Hardiman O, Mcdermott CJ, Meyer T, Mora G, Van Damme P, Van Den Berg LH, Vanhaecht K, Winkler AS, Sermeus W. A mapping review of international guidance on the management and care of amyotrophic lateral sclerosis (ALS). Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-12. PMID 27078045 DOI: 10.3109/21678421.2016.1167911 |
0.31 |
|
| 2016 |
Rutter-Locher Z, Tewkesbury D, Stephenson L, Chio A, Ellis C, Hardiman O, Leigh N, Orrell RW, Veldink JH, Visser AE, Berg LHVd, Swingler R, Shaw C, Pearce N, Al-Chalabi A. Multi-step analysis shows that late onset ALS with slow progression may represent a distinct aetiological subgroup F1000research. 5. DOI: 10.7490/F1000Research.1113415.1 |
0.38 |
|
| 2015 |
Bradley WG, Stommel EW, Shi X, Torbick NM, Caller TA, Sabel CE, Rooney JP, Staines A, Hardiman O. Spatial cluster analysis of population amyotrophic lateral sclerosis risk in Ireland. Neurology. 85: 1822-3. PMID 26574539 DOI: 10.1212/01.Wnl.0000473800.89178.A9 |
0.37 |
|
| 2015 |
Rooney JP, Tobin K, Crampsie A, Vajda A, Heverin M, McLaughlin R, Staines A, Hardiman O. Social deprivation and population density are not associated with small area risk of amyotrophic lateral sclerosis. Environmental Research. 142: 141-7. PMID 26142719 DOI: 10.1016/J.Envres.2015.06.024 |
0.324 |
|
| 2015 |
Iyer PM, Egan C, Pinto-Grau M, Burke T, Elamin M, Nasseroleslami B, Pender N, Lalor EC, Hardiman O. Functional Connectivity Changes in Resting-State EEG as Potential Biomarker for Amyotrophic Lateral Sclerosis. Plos One. 10: e0128682. PMID 26091258 DOI: 10.1371/Journal.Pone.0128682 |
0.807 |
|
| 2015 |
McLaughlin RL, Vajda A, Hardiman O. Heritability of Amyotrophic Lateral Sclerosis: Insights From Disparate Numbers. Jama Neurology. PMID 26029874 DOI: 10.1001/Jamaneurol.2014.4049 |
0.315 |
|
| 2015 |
Burke T, Elamin M, Galvin M, Hardiman O, Pender N. Caregiver burden in amyotrophic lateral sclerosis: a cross-sectional investigation of predictors. Journal of Neurology. 262: 1526-32. PMID 25904206 DOI: 10.1007/S00415-015-7746-Z |
0.331 |
|
| 2015 |
Rooney J, Vajda A, Heverin M, Elamin M, Crampsie A, McLaughlin R, Staines A, Hardiman O. Spatial cluster analysis of population amyotrophic lateral sclerosis risk in Ireland Neurology. 84: 1537-1544. PMID 25770197 DOI: 10.1212/Wnl.0000000000001477 |
0.31 |
|
| 2015 |
McLaughlin RL, Kenna KP, Vajda A, Heverin M, Byrne S, Donaghy CG, Cronin S, Bradley DG, Hardiman O. Homozygosity mapping in an Irish ALS case-control cohort describes local demographic phenomena and points towards potential recessive risk loci. Genomics. 105: 237-41. PMID 25620680 DOI: 10.1016/J.Ygeno.2015.01.002 |
0.362 |
|
| 2015 |
Rooney J, Byrne S, Heverin M, Tobin K, Dick A, Donaghy C, Hardiman O. A multidisciplinary clinic approach improves survival in ALS:A comparative study of ALS in Ireland and Northern Ireland Journal of Neurology, Neurosurgery and Psychiatry. 86: 496-501. PMID 25550416 DOI: 10.1136/Jnnp-2014-309601 |
0.366 |
|
| 2015 |
Bonini NM, Hardiman O. Ataxin-2 expands insight into the ALS clinical spectrum. Neurology. 84: 224-5. PMID 25527266 DOI: 10.1212/Wnl.0000000000001167 |
0.392 |
|
| 2015 |
Agosta F, Al-Chalabi A, Filippi M, Hardiman O, Kaji R, Meininger V, Nakano I, Shaw P, Shefner J, van den Berg LH, Ludolph A. The El Escorial criteria: strengths and weaknesses. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 16: 1-7. PMID 25482030 DOI: 10.3109/21678421.2014.964258 |
0.359 |
|
| 2015 |
McLaughlin RL, Kenna KP, Vajda A, Bede P, Elamin M, Cronin S, Donaghy CG, Bradley DG, Hardiman O. Second-generation Irish genome-wide association study for amyotrophic lateral sclerosis. Neurobiology of Aging. 36: 1221.e7-13. PMID 25442119 DOI: 10.1016/J.Neurobiolaging.2014.08.030 |
0.359 |
|
| 2015 |
Küffner R, Zach N, Norel R, Hawe J, Schoenfeld D, Wang L, Li G, Fang L, Mackey L, Hardiman O, Cudkowicz M, Sherman A, Ertaylan G, Grosse-Wentrup M, Hothorn T, et al. Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression. Nature Biotechnology. 33: 51-7. PMID 25362243 DOI: 10.1038/Nbt.3051 |
0.36 |
|
| 2015 |
Bede P, Elamin M, Byrne S, McLaughlin RL, Kenna K, Vajda A, Fagan A, Bradley DG, Hardiman O. Patterns of cerebral and cerebellar white matter degeneration in ALS. Journal of Neurology, Neurosurgery, and Psychiatry. 86: 468-70. PMID 25053771 DOI: 10.1136/Jnnp-2014-308172 |
0.442 |
|
| 2015 |
Galvin M, Madden C, Maguire S, Heverin M, Vajda A, Staines A, Hardiman O. Patient journey to a specialist amyotrophic lateral sclerosis multidisciplinary clinic: An exploratory study Bmc Health Services Research. DOI: 10.1186/S12913-015-1229-X |
0.332 |
|
| 2015 |
Burke T, Healy D, Casey P, Hardiman O, Pender N. Atypical social cognitive processing in premotor Huntington’s disease: a single case study Irish Journal of Psychological Medicine. DOI: 10.1017/Ipm.2015.48 |
0.358 |
|
| 2014 |
Smith BN, Ticozzi N, Fallini C, Gkazi AS, Topp S, Kenna KP, Scotter EL, Kost J, Keagle P, Miller JW, Calini D, Vance C, Danielson EW, Troakes C, Tiloca C, ... ... Hardiman O, et al. Exome-wide rare variant analysis identifies TUBA4A mutations associated with familial ALS. Neuron. 84: 324-31. PMID 25374358 DOI: 10.1016/J.Neuron.2014.09.027 |
0.339 |
|
| 2014 |
Al-Chalabi A, Calvo A, Chio A, Colville S, Ellis CM, Hardiman O, Heverin M, Howard RS, Huisman MH, Keren N, Leigh PN, Mazzini L, Mora G, Orrell RW, Rooney J, et al. Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study. The Lancet. Neurology. 13: 1108-13. PMID 25300936 DOI: 10.1016/S1474-4422(14)70219-4 |
0.307 |
|
| 2014 |
Diekstra FP, Van Deerlin VM, van Swieten JC, Al-Chalabi A, Ludolph AC, Weishaupt JH, Hardiman O, Landers JE, Brown RH, van Es MA, Pasterkamp RJ, Koppers M, Andersen PM, Estrada K, Rivadeneira F, et al. C9orf72 and UNC13A are shared risk loci for amyotrophic lateral sclerosis and frontotemporal dementia: a genome-wide meta-analysis. Annals of Neurology. 76: 120-33. PMID 24931836 DOI: 10.1002/Ana.24198 |
0.385 |
|
| 2014 |
Rooney J, Heverin M, Vajda A, Crampsie A, Tobin K, Byrne S, Staines A, Hardiman O. An exploratory spatial analysis of ALS incidence in Ireland over 17.5 years (1995-July 2013). Plos One. 9: e96556. PMID 24867594 DOI: 10.1371/Journal.Pone.0096556 |
0.341 |
|
| 2014 |
Pupillo E, Messina P, Giussani G, Logroscino G, Zoccolella S, Chiò A, Calvo A, Corbo M, Lunetta C, Marin B, Hardiman O, Rooney J, Stevic Z, Bandettini Di Poggio M, Filosto M, et al. Physical activity and amyotrophic lateral sclerosis: A European population-based case-control study Annals of Neurology. 75: 708-716. PMID 24706338 DOI: 10.1002/Ana.24150 |
0.331 |
|
| 2014 |
Foley G, Timonen V, Hardiman O. Understanding psycho-social processes underpinning engagement with services in motor neurone disease: A qualitative study Palliative Medicine. 28: 318-325. PMID 24637571 DOI: 10.1177/0269216313512013 |
0.34 |
|
| 2014 |
Bede P, Hardiman O. Lessons of ALS imaging: Pitfalls and future directions - A critical review. Neuroimage. Clinical. 4: 436-43. PMID 24624329 DOI: 10.1016/J.Nicl.2014.02.011 |
0.35 |
|
| 2014 |
Byrne S, Heverin M, Bede P, Elamin M, Hardiman O. Fecundity in ALS Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 15: 204-206. PMID 24479554 DOI: 10.3109/21678421.2013.865237 |
0.363 |
|
| 2014 |
Bede P, Elamin M, Byrne S, Hardiman O. Sexual dimorphism in ALS: Exploring gender-specific neuroimaging signatures Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 15: 235-242. PMID 24344910 DOI: 10.3109/21678421.2013.865749 |
0.334 |
|
| 2014 |
Murray D, Hardiman O, Meldrum D. Assessment of subjective and motor fatigue in Polio survivors, attending a Postpolio clinic, comparison with healthy controls and an exploration of clinical correlates Physiotherapy Theory and Practice. 30: 229-235. PMID 24328931 DOI: 10.3109/09593985.2013.862890 |
0.349 |
|
| 2014 |
Fogh I, Ratti A, Gellera C, Lin K, Tiloca C, Moskvina V, Corrado L, Sorarù G, Cereda C, Corti S, Gentilini D, Calini D, Castellotti B, Mazzini L, Querin G, ... ... Hardiman O, et al. A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis. Human Molecular Genetics. 23: 2220-31. PMID 24256812 DOI: 10.1093/Hmg/Ddt587 |
0.329 |
|
| 2014 |
Goris A, van Setten J, Diekstra F, Ripke S, Patsopoulos NA, Sawcer SJ, van Es M, Andersen PM, Melki J, Meininger V, Hardiman O, Landers JE, Brown RH, et al. No evidence for shared genetic basis of common variants in multiple sclerosis and amyotrophic lateral sclerosis. Human Molecular Genetics. 23: 1916-22. PMID 24234648 DOI: 10.1093/Hmg/Ddt574 |
0.334 |
|
| 2014 |
Byrne S, Heverin M, Elamin M, Walsh C, Hardiman O. Intermediate repeat expansion length in C9orf72 may be pathological in amyotrophic lateral sclerosis Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 15: 148-150. PMID 24053774 DOI: 10.3109/21678421.2013.838586 |
0.352 |
|
| 2014 |
McLaughlin RL, Kenna KP, Vajda A, Byrne S, Bradley DG, Hardiman O. UBQLN2 mutations are not a frequent cause of amyotrophic lateral sclerosis in ireland Neurobiology of Aging. 35: 267.e9-267.e11. PMID 23973441 DOI: 10.1016/J.Neurobiolaging.2013.07.023 |
0.324 |
|
| 2014 |
Bede P, Hardiman O. Subcortical gray matter structures: A future biomarker for amyotrophic lateral sclerosis? Future Neurology. 9: 109-111. DOI: 10.2217/Fnl.14.3 |
0.425 |
|
| 2013 |
Bede P, Elamin M, Byrne S, McLaughlin RL, Kenna K, Vajda A, Pender N, Bradley DG, Hardiman O. Basal ganglia involvement in amyotrophic lateral sclerosis Neurology. 81: 2107-2115. PMID 24212388 DOI: 10.1212/01.Wnl.0000437313.80913.2C |
0.433 |
|
| 2013 |
Al-Chalabi A, Hardiman O. The epidemiology of ALS: A conspiracy of genes, environment and time Nature Reviews Neurology. 9: 617-628. PMID 24126629 DOI: 10.1038/Nrneurol.2013.203 |
0.404 |
|
| 2013 |
Kenna KP, McLaughlin RL, Byrne S, Elamin M, Heverin M, Kenny EM, Cormican P, Morris DW, Donaghy CG, Bradley DG, Hardiman O. Delineating the genetic heterogeneity of ALS using targeted high-throughput sequencing. Journal of Medical Genetics. 50: 776-83. PMID 23881933 DOI: 10.1136/Jmedgenet-2013-101795 |
0.376 |
|
| 2013 |
Byrne S, Heverin M, Elamin M, Bede P, Lynch C, Kenna K, MacLaughlin R, Walsh C, Al Chalabi A, Hardiman O. Aggregation of neurologic and neuropsychiatric disease in amyotrophic lateral sclerosis kindreds: a population-based case-control cohort study of familial and sporadic amyotrophic lateral sclerosis. Annals of Neurology. 74: 699-708. PMID 23836460 DOI: 10.1002/Ana.23969 |
0.376 |
|
| 2013 |
Bede P, Bokde ALW, Byrne S, Elamin M, McLaughlin RL, Kenna K, Fagan AJ, Pender N, Bradley DG, Hardiman O. Multiparametric MRI study of ALS stratified for the C9orf72 genotype Neurology. 81: 361-369. PMID 23771489 DOI: 10.1212/Wnl.0B013E31829C5Eee |
0.428 |
|
| 2013 |
Factor-Litvak P, Al-Chalabi A, Ascherio A, Bradley W, ChÃo A, Garruto R, Hardiman O, Kamel F, Kasarskis E, McKee A, Nakano I, Nelson LM, Eisen A. Current pathways for epidemiological research in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 14: 33-43. PMID 23678878 DOI: 10.3109/21678421.2013.778565 |
0.387 |
|
| 2013 |
Fournier C, Bedlack B, Hardiman O, Heiman-Patterson T, Gutmann L, Bromberg M, Ostrow L, Carter G, Kabashi E, Bertorini T, Mozaffar T, Andersen P, Dietz J, Gamez J, et al. ALS Untangled No. 20: the Deanna protocol. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 14: 319-23. PMID 23638638 DOI: 10.3109/21678421.2013.788405 |
0.354 |
|
| 2013 |
Elamin M, Bede P, Byrne S, Jordan N, Gallagher L, Wynne B, O'Brien C, Phukan J, Lynch C, Pender N, Hardiman O. Cognitive changes predict functional decline in ALS: A population-based longitudinal study Neurology. 80: 1590-1597. PMID 23553481 DOI: 10.1212/Wnl.0B013E31828F18Ac |
0.416 |
|
| 2013 |
Turner MR, Hardiman O, Benatar M, Brooks BR, Chio A, de Carvalho M, Ince PG, Lin C, Miller RG, Mitsumoto H, Nicholson G, Ravits J, Shaw PJ, Swash M, Talbot K, et al. Controversies and priorities in amyotrophic lateral sclerosis. The Lancet. Neurology. 12: 310-22. PMID 23415570 DOI: 10.1016/S1474-4422(13)70036-X |
0.421 |
|
| 2013 |
Byrne S, Pradhan F, Dhubhghaill SN, Treacy M, Cassidy L, Hardiman O. Blink rate in ALS Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 14: 291-293. PMID 23151260 DOI: 10.3109/21678421.2012.729217 |
0.336 |
|
| 2013 |
Bede P, Bokde A, Elamin M, Byrne S, McLaughlin RL, Jordan N, Hampel H, Gallagher L, Lynch C, Fagan AJ, Pender N, Hardiman O. Grey matter correlates of clinical variables in amyotrophic lateral sclerosis (ALS): a neuroimaging study of ALS motor phenotype heterogeneity and cortical focality. Journal of Neurology, Neurosurgery, and Psychiatry. 84: 766-73. PMID 23085933 DOI: 10.1136/Jnnp-2012-302674 |
0.506 |
|
| 2013 |
van Rheenen W, Diekstra FP, van Doormaal PT, Seelen M, Kenna K, McLaughlin R, Shatunov A, Czell D, van Es MA, van Vught PW, van Damme P, Smith BN, Waibel S, Schelhaas HJ, van der Kooi AJ, ... ... Hardiman O, et al. H63D polymorphism in HFE is not associated with amyotrophic lateral sclerosis. Neurobiology of Aging. 34: 1517.e5-7. PMID 23063643 DOI: 10.1016/J.Neurobiolaging.2012.07.020 |
0.36 |
|
| 2012 |
Van Hoecke A, Schoonaert L, Lemmens R, Timmers M, Staats KA, Laird AS, Peeters E, Philips T, Goris A, Dubois B, Andersen PM, Al-Chalabi A, Thijs V, Turnley AM, van Vught PW, ... ... Hardiman O, et al. EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans. Nature Medicine. 18: 1418-22. PMID 22922411 DOI: 10.1038/Nm.2901 |
0.426 |
|
| 2012 |
Bedlack R, Hardiman O, Heiman-Patterson T, Gutmann L, Bromberg M, Ostrow L, Carter G, Kabashi E, Bertorini T, Mozaffar T, Andersen P, Dietz J, Gamez J, Dimachkie M, Wang Y, et al. ALS untangled no. 17: "When ALS Is Lyme" Amyotrophic Lateral Sclerosis. 13: 487-491. PMID 22873562 DOI: 10.3109/17482968.2012.717796 |
0.363 |
|
| 2012 |
Hardiman O, Figlewicz DA. The expansions of ALS. Neurology. 79: 842-3. PMID 22843260 DOI: 10.1212/Wnl.0B013E3182662031 |
0.49 |
|
| 2012 |
Diekstra FP, Saris CG, van Rheenen W, Franke L, Jansen RC, van Es MA, van Vught PW, Blauw HM, Groen EJ, Horvath S, Estrada K, Rivadeneira F, Hofman A, Uitterlinden AG, Robberecht W, ... ... Hardiman O, et al. Mapping of gene expression reveals CYP27A1 as a susceptibility gene for sporadic ALS. Plos One. 7: e35333. PMID 22509407 DOI: 10.1371/Journal.Pone.0035333 |
0.378 |
|
| 2012 |
Byrne S, Elamin M, Bede P, Hardiman O. Absence of consensus in diagnostic criteria for familial neurodegenerative diseases Journal of Neurology, Neurosurgery and Psychiatry. 83: 365-367. PMID 22399794 DOI: 10.1136/Jnnp-2011-301530 |
0.331 |
|
| 2012 |
Byrne S, Elamin M, Bede P, Shatunov A, Walsh C, Corr B, Heverin M, Jordan N, Kenna K, Lynch C, McLaughlin RL, Iyer PM, O'Brien C, Phukan J, Wynne B, ... ... Hardiman O, et al. Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: A population-based cohort study The Lancet Neurology. 11: 232-240. PMID 22305801 DOI: 10.1016/S1474-4422(12)70014-5 |
0.456 |
|
| 2012 |
Hardiman O. Multidisciplinary care in ALS: Expanding the team Amyotrophic Lateral Sclerosis. 13: 165. PMID 22292839 DOI: 10.3109/17482968.2012.657006 |
0.302 |
|
| 2012 |
Foley G, Timonen V, Hardiman O. Experience of Services as a Key Outcome in Amyotrophic Lateral Sclerosis (ALS) Care: The Case for a Better Understanding of Patient Experiences American Journal of Hospice and Palliative Medicine. 29: 362-367. PMID 21998444 DOI: 10.1177/1049909111423774 |
0.305 |
|
| 2012 |
Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, Van Damme P, Hardiman O, Kollewe K, Morrison KE, Petri S, Pradat PF, Silani V, Tomik B, Wasner M, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)--revised report of an EFNS task force. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 19: 360-75. PMID 21914052 DOI: 10.1111/J.1468-1331.2011.03501.X |
0.314 |
|
| 2012 |
Phukan J, Elamin M, Bede P, Jordan N, Gallagher L, Byrne S, Lynch C, Pender N, Hardiman O. The syndrome of cognitive impairment in amyotrophic lateral sclerosis: A population-based study Journal of Neurology, Neurosurgery and Psychiatry. 83: 102-108. PMID 21836033 DOI: 10.1136/Jnnp-2011-300188 |
0.374 |
|
| 2012 |
Al-Chalabi A, Hardiman O. Ask the Experts: Translating amyotrophic lateral sclerosis genetics to the clinic: implications for the patient Neurodegenerative Disease Management. 2: 355-360. DOI: 10.2217/Nmt.12.40 |
0.335 |
|
| 2012 |
Elamin M, Bede P, Byrne S, Jordan N, Gallagher L, Lynch C, O'Brien C, Wynne B, Pender N, Hardiman O. Are Cognitive Changes in Amyotrophic Lateral Sclerosis Markers for Distinct Disease Subtypes? A Population-Based Longitudinal Study (S25.007) Neurology. 78. DOI: 10.1212/Wnl.78.1_Meetingabstracts.S25.007 |
0.438 |
|
| 2012 |
Byrne S, Shatunov A, Bede P, Elamin M, Lynch C, Kenna K, McLaughlin R, Pender N, Bradley D, Al-Chalabi A, Hardiman O. The Population Based Prevalence and Phenotype of 9p21 Hexanucleotide Repeats in ALS/FTD (IN9-1.005) Neurology. 78: IN9-1.005-IN9-1.005. DOI: 10.1212/Wnl.78.1_Meetingabstracts.In9-1.005 |
0.398 |
|
| 2011 |
Bede P, Oliver D, Stodart J, van den Berg L, Simmons Z, Ó Brannagáin D, Borasio GD, Hardiman O. Palliative care in amyotrophic lateral sclerosis: a review of current international guidelines and initiatives. Bmj Supportive & Palliative Care. 1: 343-8. PMID 24653482 DOI: 10.1136/Bmjspcare.2010.232637.Rep |
0.32 |
|
| 2011 |
Hardiman O, Van Den Berg LH, Kiernan MC. Clinical diagnosis and management of amyotrophic lateral sclerosis Nature Reviews Neurology. 7: 639-649. PMID 21989247 DOI: 10.1038/Nrneurol.2011.153 |
0.401 |
|
| 2011 |
Geser F, Prvulovic D, O'Dwyer L, Hardiman O, Bede P, Bokde AL, Trojanowski JQ, Hampel H. On the development of markers for pathological TDP-43 in amyotrophic lateral sclerosis with and without dementia. Progress in Neurobiology. 95: 649-62. PMID 21911035 DOI: 10.1016/J.Pneurobio.2011.08.011 |
0.431 |
|
| 2011 |
Hardiman O. Amyotrophic lateral sclerosis and vascular risk: A metabolic conundrum Journal of Neurology, Neurosurgery and Psychiatry. 82: 591. PMID 21551170 DOI: 10.1136/Jnnp.2011.241539 |
0.427 |
|
| 2011 |
Bede P, Bokde ALW, Byrne SC, Elamin M, Walsh RJ, Hardiman O. Waterskier's Hirayama syndrome Journal of Neurology. 258: 2078-2079. PMID 21503827 DOI: 10.1007/S00415-011-6046-5 |
0.357 |
|
| 2011 |
Elamin M, Phukan J, Bede P, Jordan N, Byrne S, Pender N, Hardiman O. Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia Neurology. 76: 1263-1269. PMID 21464431 DOI: 10.1212/Wnl.0B013E318214359F |
0.365 |
|
| 2011 |
Bede P, Oliver D, Stodart J, Van Den Berg L, Simmons Z, Brannagáin DO, Borasio GD, Hardiman O. Palliative care in amyotrophic lateral sclerosis: A review of current international guidelines and initiatives Journal of Neurology, Neurosurgery and Psychiatry. 82: 413-418. PMID 21297150 DOI: 10.1136/Jnnp.2010.232637 |
0.32 |
|
| 2011 |
Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, Burrell JR, Zoing MC. Amyotrophic lateral sclerosis. Lancet. 377: 942-55. PMID 21296405 DOI: 10.1016/S0140-6736(10)61156-7 |
0.323 |
|
| 2011 |
Hardiman O. Management of respiratory symptoms in ALS Journal of Neurology. 258: 359-365. PMID 21082322 DOI: 10.1007/S00415-010-5830-Y |
0.322 |
|
| 2011 |
Beghi E, Chiò A, Couratier P, Esteban J, Hardiman O, Logroscino G, Millul A, Mitchell D, Preux PM, Pupillo E, Stevic Z, Swingler R, Traynor BJ, Van den Berg LH, Veldink JH, et al. The epidemiology and treatment of ALS: focus on the heterogeneity of the disease and critical appraisal of therapeutic trials. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 12: 1-10. PMID 20698807 DOI: 10.3109/17482968.2010.502940 |
0.316 |
|
| 2010 |
Shatunov A, Mok K, Newhouse S, Weale ME, Smith B, Vance C, Johnson L, Veldink JH, van Es MA, van den Berg LH, Robberecht W, Van Damme P, Hardiman O, Farmer AE, Lewis CM, et al. Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study. The Lancet. Neurology. 9: 986-94. PMID 20801717 DOI: 10.1016/S1474-4422(10)70197-6 |
0.368 |
|
| 2010 |
Blauw HM, Al-Chalabi A, Andersen PM, van Vught PWJ, Diekstra FP, van Es MA, Saris CGJ, Groen EJN, van Rheenen W, Koppers M, Slot Rvt, Strengman E, Estrada K, Rivadeneira F, Hofman A, ... ... Hardiman O, et al. A large genome scan for rare CNVs in amyotrophic lateral sclerosis Human Molecular Genetics. 19: 4091-4099. PMID 20685689 DOI: 10.1093/Hmg/Ddq323 |
0.373 |
|
| 2010 |
Donaghy C, Clarke J, Patterson C, Kee F, Hardiman O, Patterson V. The epidemiology of motor neuron disease in Northern Ireland using capture-recapture methodology. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 11: 374-8. PMID 20550486 DOI: 10.3109/17482960903329569 |
0.305 |
|
| 2010 |
Beghi E, Logroscino G, Chiò A, Hardiman O, Millul A, Mitchell D, Swingler R, Traynor BJ. Amyotrophic lateral sclerosis, physical exercise, trauma and sports: results of a population-based pilot case-control study. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 11: 289-92. PMID 20433412 DOI: 10.3109/17482960903384283 |
0.308 |
|
| 2010 |
Yeo L, Lynch C, Hardiman O. Validating population-based registers for ALS: How accurate is death certification? Journal of Neurology. 257: 1235-1239. PMID 20151145 DOI: 10.1007/S00415-010-5494-7 |
0.396 |
|
| 2010 |
Donaghy C, Pinnock R, Abrahams S, Cardwell C, Hardiman O, Patterson V, McGivern RC, Gibson JM. Slow saccades in bulbar-onset motor neurone disease Journal of Neurology. 257: 1134-1140. PMID 20146069 DOI: 10.1007/S00415-010-5478-7 |
0.304 |
|
| 2010 |
Logroscino G, Traynor BJ, Hardiman O, Chiò A, Mitchell D, Swingler RJ, Millul A, Benn E, Beghi E. Incidence of amyotrophic lateral sclerosis in Europe. Journal of Neurology, Neurosurgery, and Psychiatry. 81: 385-90. PMID 19710046 DOI: 10.1136/Jnnp.2009.183525 |
0.344 |
|
| 2010 |
Phukan J, Ali E, Pender NP, Molloy F, Hennessy M, Walsh RJ, Hardiman O. Huntington's disease presenting as amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 11: 405-7. PMID 19530012 DOI: 10.1080/17482960903055958 |
0.371 |
|
| 2010 |
Phukan J, Hardiman O, Jordan N, Gallagher L, Pender NP. PATU4 A population-based longitudinal study of cognitive and behavioural impairment in amyotrophic lateral sclerosis Journal of Neurology, Neurosurgery, and Psychiatry. 81. DOI: 10.1136/Jnnp.2010.226340.33 |
0.357 |
|
| 2009 |
Chiò A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, Traynor BG. Prognostic factors in ALS: A critical review. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 10: 310-23. PMID 19922118 DOI: 10.3109/17482960802566824 |
0.332 |
|
| 2009 |
Hardiman O. Ten years of the ALS journal. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 10: 257. PMID 19922111 DOI: 10.3109/17482960903363287 |
0.342 |
|
| 2009 |
Landers JE, Melki J, Meininger V, Glass JD, van den Berg LH, van Es MA, Sapp PC, van Vught PW, McKenna-Yasek DM, Blauw HM, Cho TJ, Polak M, Shi L, Wills AM, Broom WJ, ... ... Hardiman O, et al. Reduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis. Proceedings of the National Academy of Sciences of the United States of America. 106: 9004-9. PMID 19451621 DOI: 10.1073/Pnas.0812937106 |
0.362 |
|
| 2009 |
Wills AM, Cronin S, Slowik A, Kasperaviciute D, Van Es MA, Morahan JM, Valdmanis PN, Meininger V, Melki J, Shaw CE, Rouleau GA, Fisher EM, Shaw PJ, Morrison KE, Pamphlett R, ... ... Hardiman O, et al. A large-scale international meta-analysis of paraoxonase gene polymorphisms in sporadic ALS. Neurology. 73: 16-24. PMID 19321847 DOI: 10.1212/Wnl.0B013E3181A18674 |
0.316 |
|
| 2009 |
Donaghy C, Pinnock R, Abrahams S, Cardwell C, Hardiman O, Patterson V, McGivern RC, Gibson JM. Ocular fixation instabilities in motor neurone disease. A marker of frontal lobe dysfunction? Journal of Neurology. 256: 420-6. PMID 19306041 DOI: 10.1007/S00415-009-0109-X |
0.369 |
|
| 2009 |
Phukan J, Hardiman O. The management of amyotrophic lateral sclerosis Journal of Neurology. 256: 176-186. PMID 19224316 DOI: 10.1007/S00415-009-0142-9 |
0.408 |
|
| 2009 |
Donaghy C, O'Toole O, Sheehan C, Kee F, Hardiman O, Patterson V. An all-Ireland epidemiological study of MND, 2004-2005 European Journal of Neurology. 16: 148-153. PMID 19087159 DOI: 10.1111/J.1468-1331.2008.02361.X |
0.343 |
|
| 2009 |
Cronin S, Tomik B, Bradley DG, Slowik A, Hardiman O. Screening for replication of genome-wide SNP associations in sporadic ALS European Journal of Human Genetics. 17: 213-218. PMID 18987618 DOI: 10.1038/Ejhg.2008.194 |
0.313 |
|
| 2009 |
Fallis BA, Hardiman O. Aggregation of neurodegenerative disease in ALS kindreds Amyotrophic Lateral Sclerosis. 10: 95-98. PMID 18608094 DOI: 10.1080/17482960802209664 |
0.397 |
|
| 2008 |
Kieran D, Sebastia J, Greenway MJ, King MA, Connaughton D, Concannon CG, Fenner B, Hardiman O, Prehn JHM. Control of motoneuron survival by angiogenin Journal of Neuroscience. 28: 14056-14061. PMID 19109488 DOI: 10.1523/Jneurosci.3399-08.2008 |
0.303 |
|
| 2008 |
Cronin S, Blauw HM, Veldink JH, Van Es MA, Ophoff RA, Bradley DG, van den Berg LH, Hardiman O. Analysis of genome-wide copy number variation in Irish and Dutch ALS populations Human Molecular Genetics. 17: 3392-3398. PMID 18689356 DOI: 10.1093/Hmg/Ddn233 |
0.372 |
|
| 2008 |
Meisler MH, Russ C, Montgomery KT, Greenway M, Ennis S, Hardiman O, Figlewicz DA, Quenneville NR, Conibear E, Brown RH. Evaluation of the Golgi trafficking protein VPS54 (wobbler) as a candidate for ALS. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 9: 141-8. PMID 18574757 DOI: 10.1080/17482960801934403 |
0.375 |
|
| 2008 |
Logroscino G, Traynor BJ, Hardiman O, Chio' A, Couratier P, Mitchell JD, Swingler RJ, Beghi E. Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. Journal of Neurology, Neurosurgery, and Psychiatry. 79: 6-11. PMID 18079297 DOI: 10.1136/Jnnp.2006.104828 |
0.347 |
|
| 2008 |
Cronin S, Berger S, Ding J, Schymick JC, Washecka N, Hernandez DG, Greenway MJ, Bradley DG, Traynor BJ, Hardiman O. A genome-wide association study of sporadic ALS in a homogenous Irish population. Human Molecular Genetics. 17: 768-74. PMID 18057069 DOI: 10.1093/Hmg/Ddm361 |
0.325 |
|
| 2008 |
Chiò A, Traynor BJ, Swingler R, Mitchell D, Hardiman O, Mora G, Beghi E, Logroscino G. Amyotrophic lateral sclerosis and soccer: a different epidemiological approach strengthen the previous findings. Journal of the Neurological Sciences. 269: 187-8; author reply . PMID 17996254 DOI: 10.1016/J.Jns.2007.10.005 |
0.311 |
|
| 2008 |
O'Toole O, Traynor BJ, Brennan P, Sheehan C, Frost E, Corr B, Hardiman O. Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004. Journal of Neurology, Neurosurgery, and Psychiatry. 79: 30-2. PMID 17634215 DOI: 10.1136/Jnnp.2007.117788 |
0.388 |
|
| 2007 |
Beghi E, Mennini T, Bendotti C, Bigini P, Logroscino G, Chiò A, Hardiman O, Mitchell D, Swingler R, Traynor BJ, Al-Chalabi A. The heterogeneity of amyotrophic lateral sclerosis: a possible explanation of treatment failure. Current Medicinal Chemistry. 14: 3185-200. PMID 18220753 DOI: 10.2174/092986707782793862 |
0.449 |
|
| 2007 |
Phukan J, Pender NP, Hardiman O. Cognitive impairment in amyotrophic lateral sclerosis Lancet Neurology. 6: 994-1003. PMID 17945153 DOI: 10.1016/S1474-4422(07)70265-X |
0.47 |
|
| 2007 |
Miller R, Bradley W, Cudkowicz M, Hubble J, Meininger V, Mitsumoto H, Moore D, Pohlmann H, Sauer D, Silani V, Strong M, Swash M, Vernotica E, Cashman N, Eisen A, ... ... Hardiman O, et al. Phase II/III randomized trial of TCH346 in patients with ALS Neurology. 69: 776-784. PMID 17709710 DOI: 10.1212/01.Wnl.0000269676.07319.09 |
0.319 |
|
| 2007 |
Hosback S, Hardiman O, Nolan CM, Doyle MAC, Gorman G, Lynch C, O'Toole O, Jakeman P. Circulating insulin-like growth factors and related binding proteins are selectively altered in amyotrophic lateral sclerosis and multiple sclerosis Growth Hormone and Igf Research. 17: 472-479. PMID 17697791 DOI: 10.1016/J.Ghir.2007.06.002 |
0.33 |
|
| 2007 |
Andersen PM, Borasio GD, Dengler R, Hardiman O, Kollewe K, Leigh PN, Pradat PF, Silani V, Tomik B. Good practice in the management of amyotrophic lateral sclerosis: Clinical guidelines. An evidence-based review with good practice points. EALSC Working Group Amyotrophic Lateral Sclerosis. 8: 195-213. PMID 17653917 DOI: 10.1080/17482960701262376 |
0.305 |
|
| 2007 |
Meldrum D, Cahalane E, Conroy R, Guthrie R, Hardiman O. Quantitative assessment of motor fatigue: Normative values and comparison with prior-polio patients Amyotrophic Lateral Sclerosis. 8: 170-176. PMID 17538779 DOI: 10.1080/17482960701223113 |
0.315 |
|
| 2007 |
Foley G, O'Mahony P, Hardiman O. Perceptions of quality of life in people with ALS: Effects of coping and health care Amyotrophic Lateral Sclerosis. 8: 164-169. PMID 17538778 DOI: 10.1080/17482960601164532 |
0.33 |
|
| 2007 |
Cronin S, Hardiman O, Traynor BJ. Ethnic variation in the incidence of ALS: a systematic review. Neurology. 68: 1002-7. PMID 17389304 DOI: 10.1212/01.Wnl.0000258551.96893.6F |
0.327 |
|
| 2007 |
Schymick JC, Yang Y, Andersen PM, Vonsattel JP, Greenway M, Momeni P, Elder J, Chiò A, Restagno G, Robberecht W, Dahlberg C, Mukherjee O, Goate A, Graff-Radford N, Caselli RJ, ... ... Hardiman O, et al. Progranulin mutations and amyotrophic lateral sclerosis or amyotrophic lateral sclerosis-frontotemporal dementia phenotypes. Journal of Neurology, Neurosurgery, and Psychiatry. 78: 754-6. PMID 17371905 DOI: 10.1136/Jnnp.2006.109553 |
0.396 |
|
| 2006 |
Cronin S, Greenway MJ, Ennis S, Kieran D, Green A, Prehn JHM, Hardiman O. Elevated serum angiogenin levels in ALS Neurology. 67: 1833-1836. PMID 17130418 DOI: 10.1212/01.Wnl.0000244466.46020.47 |
0.362 |
|
| 2006 |
Parkinson N, Ince PG, Smith MO, Highley R, Skibinski G, Andersen PM, Morrison KE, Pall HS, Hardiman O, Collinge J, Shaw PJ, Fisher EM. ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B). Neurology. 67: 1074-7. PMID 16807408 DOI: 10.1212/01.Wnl.0000231510.89311.8B |
0.43 |
|
| 2006 |
Greenway MJ, Andersen PM, Russ C, Ennis S, Cashman S, Donaghy C, Patterson V, Swingler R, Kieran D, Prehn J, Morrison KE, Green A, Acharya KR, Brown RH, Hardiman O. ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis. Nature Genetics. 38: 411-3. PMID 16501576 DOI: 10.1038/Ng1742 |
0.423 |
|
| 2005 |
Andersen PM, Borasio GD, Dengler R, Hardiman O, Kollewe K, Leigh PN, Pradat PF, Silani V, Tomik B. EFNS task force on management of amyotrophic lateral sclerosis: Guidelines for diagnosing and clinical care of patients and relatives: An evidence-based review with good practice points European Journal of Neurology. 12: 921-938. PMID 16324086 DOI: 10.1111/J.1468-1331.2005.01351.X |
0.319 |
|
| 2005 |
Goodall EF, Greenway MJ, Van Marion I, Carroll CB, Hardiman O, Morrison KE. Association of the H63D polymorphism in the hemochromatosis gene with sporadic ALS Neurology. 65: 934-937. PMID 16186539 DOI: 10.1212/01.Wnl.0000176032.94434.D4 |
0.346 |
|
| 2004 |
Greenway MJ, Alexander MD, Ennis S, Traynor BJ, Corr B, Frost E, Green A, Hardiman O. A novel candidate region for ALS on chromosome 14q11.2. Neurology. 63: 1936-8. PMID 15557516 DOI: 10.1212/01.Wnl.0000144344.39103.F6 |
0.304 |
|
| 2004 |
Kidney D, Alexander M, Corr B, O'Toole O, Hardiman O. Oropharyngeal dysphagia in amyotrophic lateral sclerosis: Neurological and dysphagia specific rating scales Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders. 5: 150-153. PMID 15512903 DOI: 10.1080/14660820410019675 |
0.358 |
|
| 2003 |
Traynor BJ, Alexander M, Corr B, Frost E, Hardiman O. Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000. Journal of Neurology, Neurosurgery, and Psychiatry. 74: 1258-61. PMID 12933930 DOI: 10.1136/Jnnp.74.9.1258 |
0.38 |
|
| 2003 |
Ryan A, Nor AM, Costigan D, Foley-Nolan D, El-Rafie A, Farrell MA, Hardiman O. Polymyositis masquerading as motor neuron disease. Archives of Neurology. 60: 1001-3. PMID 12873858 DOI: 10.1001/Archneur.60.7.1001 |
0.374 |
|
| 2003 |
Traynor BJ, Alexander M, Corr B, Frost E, Hardiman O. An outcome study of riluzole in amyotrophic lateral sclerosis--a population-based study in Ireland, 1996-2000. Journal of Neurology. 250: 473-9. PMID 12700914 DOI: 10.1007/S00415-003-1026-Z |
0.367 |
|
| 2002 |
Hardiman O, Traynor BJ, Corr B, Frost E. Models of care for motor neuron disease: setting standards. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group On Motor Neuron Diseases. 3: 182-5. PMID 12710506 DOI: 10.1080/146608202760839002 |
0.361 |
|
| 2002 |
Alexander MD, Traynor BJ, Miller N, Corr B, Frost E, McQuaid S, Brett FM, Green A, Hardiman O. "True" sporadic ALS associated with a novel SOD-1 mutation. Annals of Neurology. 52: 680-3. PMID 12402272 DOI: 10.1002/Ana.10369 |
0.328 |
|
| 2001 |
Borasio G, Shaw P, Hardiman O, Ludolph A, Luis MS, Silani V. Standards of palliative care for patients with amyotrophic lateral sclerosis: results of a European survey. Amyotrophic Lateral Sclerosis. 2: 159-164. PMID 11771773 DOI: 10.1080/146608201753275517 |
0.343 |
|
| 2001 |
Clarke S, Hickey A, O'Boyle C, Hardiman O. Assessing individual quality of life in amyotrophic lateral sclerosis. Quality of Life Research. 10: 149-158. PMID 11642685 DOI: 10.1023/A:1016704906100 |
0.378 |
|
| 2000 |
Hardiman O. Pitfalls in the diagnosis of motor neurone disease. Hospital Medicine. 61: 767-771. PMID 11198744 DOI: 10.12968/Hosp.2000.61.11.1461 |
0.389 |
|
| 2000 |
Hardiman O. Symptomatic treatment of respiratory and nutritional failure in amyotrophic lateral sclerosis. Journal of Neurology. 247: 245-251. PMID 10836614 DOI: 10.1007/S004150050578 |
0.382 |
|
| 2000 |
Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman O. Amyotrophic lateral sclerosis mimic syndromes: a population-based study. Archives of Neurology. 57: 109-13. PMID 10634456 DOI: 10.1001/Archneur.57.1.109 |
0.408 |
|
| 1999 |
Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman O. Incidence and prevalence of ALS in Ireland, 1995-1997: a population-based study. Neurology. 52: 504-9. PMID 10025778 DOI: 10.1212/Wnl.52.3.504 |
0.322 |
|
| 1998 |
Corr B, Frost E, Traynor BJ, Hardiman O. Service provision for patients with ALS/MND: a cost-effective multidisciplinary approach. Journal of the Neurological Sciences. 160: S141-5. PMID 9851665 DOI: 10.1016/S0022-510X(98)00214-7 |
0.331 |
|
| Show low-probability matches. |